Clinical features of stroke-associated pneumonia in the elderly patients

doi:10.3877/cma.j.issn.2095-9133.2016.02.010

Abstract

Abstract:

Objective

To analyze the clinical characteristics of elderly patients of acute stroke complicated with pulmonary infection.

Methods

963 cases of elderly stroke patients were retrospectively analyzed, which were enrolled in The third Affiliated Hospital of Southern Medical University from January 2009 to October 2015. According to the diagnosis and treatment of stroke associated pneumonia Chinese expert consensus, 223 cases of SAP patients were enrolled and divided into early SAP group and late SAP group according to fever time for hospitalization for 48 h. The clinical characteristics of patients with SAP were analyzed.

Results

The hospitalization time of early SAP group was (25±8) d and hospitalization time of late SAP group was (10±6) d. The difference was statically significant. Mortality rates of two groups was 35.4% and 10.0%, respectively. The difference of the mortality rate was statically significant. Klebsiella pneumoniae (18%), Staphylococcus aureus (12%), Acinetobacter (10%), Escherichia coli (5%), Pseudomonas aeruginosa (6%) were the major pathogenic bacteria.

Conclusion

Occurrence of acute cerebral stroke elderly associated pneumonia is closely related to many factors (choking cough, disturbance of consciousness, hypertension, diabetes, pulmonary heart disease, primary disease).

Key words: Advanced age, stroke, pulmonary infection

Duxun Tan, Lihua Xiao, Zeyu Yan, Xiongwei Ye, Jinhong Wang. Clinical features of stroke-associated pneumonia in the elderly patients[J]. Chinese Journal of Hygiene Rescue(Electronic Edition), 2016, 02(02): 107-110.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhwsyjdzzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2095-9133.2016.02.010

https://zhwsyjdzzz.cma-cmc.com.cn/EN/Y2016/V02/I02/107

Figures/Tables 3

References 15

1	Teramoto S. Novel preventive and therapeutic strategy for post-stroke pneumonia[J]. Expert Rev Neurother, 2009, 9(8): 1187-1200.
2	于庆海，董彦慧．老年脑卒中患者复发的危险因素临床分析[J]．河北医学，2015，21(11)：1880-1883.
3	Hiker R, Poetter C, Findeisen N, et al.Nosocomial pneumonia after acute stroke: implications for neurological intensive care mendicine[J]. Stroke, 2003, 34(4): 975-981.
4	卒中相关性肺炎诊治中国专家共识组．卒中相关性肺炎诊治中国专家共识[J]．中华内科杂志，2010，49(12)：1075-1078.
5	Himhcy JA, Shephard T, Funie, et al.Formal dysphagia screening protocols prevent pneumonia[J]. Strok, 2005, 36: 2756-2763.
6	大西幸子，孙启良．摄食·吞咽障碍康复实用技术[M]．北京：人民卫生出版社，2000：43-44.
7	Madden KP, Karanjia PN, Adams HP, et al. Accuracy of initial stroke subtype diagnosis in the TOAST study.Trial of Org 10 172 in Acute Stoke Treatmnet[J]. Neuology, 1995, 45: 1975-1979.
8	徐晓鸿．不同入院途径老年脑卒中相关性肺炎多重耐药菌的分布特点及感染防控研究[J]．中国实用神经疾病杂志，2015，(16)：13-15.
9	Sui R, Zhang L. Risk factor of stroke-associated pneumonia in Chinese patients[J]. Neurol Res, 2011, 33(5): 508-513.
10	Klehmet J, Harms H, Richter M, et al.Stroke-induced immunodepression and post-stroke infections: lessons from the preven-tive antibacterial therapy in stroke trial [J]. Neuroscience, 2009, 158(3): 1184-1193.
11	黄玲．老年重症肺炎56例临床分析及防治[J]．临床肺科杂志，2009，14(8)：1027.
12	Teramoto S, Fukuchi Y, Sasaki H, et al.Japanese study group on aspiration pulmonary disease: high incidence of aspiration pneumonia in community-and hospital-acquired pneumonia in hospitalized patients: a multicenter, prospective study in Japan [J]. J AmGeriatr Soc, 2008, 56(3): 577-579.
13	刘莹莹，刘持善，付秀丽，等．脑卒中相关性肺炎的危险因素[J]．山东大学学报(医学版)，2012，50(7)：60-64.
14	汤辉，秦俭，曹涛，等．老年脑卒中后肺炎的多因素Logistic回归分析[J]．中国实用神经疾病杂志，2015，18(10)：46-48.
15	Jayasekeran V, Singh S, Tyrrell P, et al.Adjunctive functional pharyngeal electrical stimulation reverses swallowing disability afterbrain lesions[J]. Gastroenterology, 2010, 138(5): 1737-1746.

组别	例数	年龄(岁，±s)	性别(男/女)	卒中类型(梗死/出血)	住院时间(±s，d)	病死率(%)
SAP组	223	78±8	132/91	121/102	25±8	35.4
非SAP组	200	75±10	120/80	105/95	10±6	10.0
T/χ²值	?	1.665	0.029	0.131	8.112	38.023
P值	?	>0.05	>0.05	>0.05	<0.05	<0.05

组别	例数	年龄(岁，±s)	性别(男/女)	卒中类型(梗死/出血)	住院时间(±s，d)	病死率(%)
SAP组	223	78±8	132/91	121/102	25±8	35.4
非SAP组	200	75±10	120/80	105/95	10±6	10.0
T/χ²值	?	1.665	0.029	0.131	8.112	38.023
P值	?	>0.05	>0.05	>0.05	<0.05	<0.05

组别	例数	年龄(岁，±s)	性别(男/女)	卒中类型(梗死/出血)	痰培养阳性率(%)	肺CT阳性率(%)	原有基础病(例)	意识障碍(例)	呛咳(例)	肾上腺皮质激素(例)
存活组	153	77±7	89/64	89/64	53	42	30	47	60	29
死亡组	70	79±7	54/16	48/22	20	18	17	34	42	45
t/χ²值	?	－1.678	7.515	2.193	0.803	0.074	0.632	6.618	8.359	44.512
P值	?	>0.05	<0.05	>0.05	>0.05	>0.05	>0.05	<0.05	<0.05	<0.05

组别	例数	年龄(岁，±s)	性别(男/女)	卒中类型(梗死/出血)	痰培养阳性率(%)	肺CT阳性率(%)	原有基础病(例)	意识障碍(例)	呛咳(例)	肾上腺皮质激素(例)
存活组	153	77±7	89/64	89/64	53	42	30	47	60	29
死亡组	70	79±7	54/16	48/22	20	18	17	34	42	45
t/χ²值	?	－1.678	7.515	2.193	0.803	0.074	0.632	6.618	8.359	44.512
P值	?	>0.05	<0.05	>0.05	>0.05	>0.05	>0.05	<0.05	<0.05	<0.05

组别	例数	年龄(岁，±s)	性别(男/女)	卒中类型(梗死/出血)	痰培养阳性率(%)	肺CT阳性率(%)	原有基础病(例)	意识障碍(例)	呛咳(例)
早发组	145	79±5	81/64	89/56	38	49	59	55	65
晚发组	78	78±5	42/36	50/28	33	43	29	24	39
t/χ²值	?	0.851	0.083	0.160	6.058	9.526	0.262	1.137	0.545
P值	?	>0.05	>0.05	>0.05	<0.05	<0.05	>0.05	>0.05	>0.05

Please choose a citation manager

Content to export